Hayden James McRobbie

Professor Hayden James McRobbie is a health behavior change expert specializing in tobacco dependence and obesity management. He holds a Professorship at the University of New South Wales' National Drug and Alcohol Research Centre and serves as a Consultant in Lifestyle Medicine at New Zealand's Lakes District Health Board. A Fellow of the Australasian Society for Lifestyle Medicine, he focuses on randomized controlled trials (RCTs), cohort studies, and surveys, particularly in electronic cigarette efficacy, digital cessation strategies, and weight management interventions.

Education: MB, ChB from the University of Otago (1996), PhD in Medical Psychology from the University of London (2008). Key roles include Clinical Champion in Child Obesity for New Zealand's Ministry of Health (2019–2022) and editorial board memberships at Addiction and Nicotine & Tobacco Research. His research emphasizes equity in smoking cessation, addressing low-socioeconomic populations and mental health comorbidities.

Research Contributions: Over 198 journal articles and 15+ major grants, including trials evaluating e-cigarettes, cytisine, and varenicline. Notable studies include the Pregnancy Trial of E-cigarettes and Patches (PREP) and a randomized trial comparing tailored text messaging versus Quitline for smoking cessation.

Awards: Jarvik-Russell Early Career Award (SRNT, 2019) for exceptional contributions to nicotine/tobacco research. His work bridges clinical practice and public health policy, with a focus on innovative cessation tools and vulnerable populations.